Modified Ferriman-Gallwey Score in Hirsutism and its Association with Metabolic Syndrome
- PMID: 28761258
- PMCID: PMC5514800
- DOI: 10.4103/ijt.ijt_93_16
Modified Ferriman-Gallwey Score in Hirsutism and its Association with Metabolic Syndrome
Abstract
Background: Hirsutism is the presence of terminal hair in females in males pattern. It occurs in 5%-15% of women. Modified Ferriman-Gallwey (mFG) score of ≥ 8 is considered hirsutism, but there are populations with a low mFG score. In clinical practice, hirsutism is subjective. Although hirsutism is considered as a purely esthetic problem, it is associated with many underlying disorders, especially androgen excess disorders. Polycystic ovarian syndrome (PCOS) disease is the most common cause of androgen excess in females, and there are reports of its association with metabolic syndrome. Metabolic syndrome occurs alone in hirsutism.
Aims: To assess mFG score in patients who consider themselves as hirsute. To study the association between metabolic syndrome and hirsutism.
Methods: Hospital-based cross-sectional study design was adopted. A structured questionnaire was used to collect sociodemographic and clinical data. The severity of hirsutism was assessed using mFG score and metabolic syndrome was diagnosed by the American Heart Association criteria. mFG score was expressed as mean and Student's t-test and Chi-square statistic were used as the tests of significance. Logistic regression analysis was performed.
Results: The mean mFG score was 5.5. Metabolic syndrome was present in 44%. About 65.2% of patients with score ≥8 had metabolic syndrome, whereas only 37.7% of patients with score <8 had metabolic syndrome (P = 0.019). Metabolic syndrome (P = 0.018) and PCOS (P = 0.003) were the significant variables in logistic regression analysis. Triglyceride levels ≥150 mg/dl and waist circumference ≥88 cm were the components of metabolic syndrome that were significantly associated with hirsutism (P = 0.006 in both).
Conclusions: To find the ideal cutoff of mFG score to define hirsutism in our population, a population study among females in the reproductive age group has to be conducted. As there is a definite association of hirsutism and metabolic syndrome, and metabolic syndrome can result in cardiovascular complications, any women presenting with terminal hair in a male pattern should be evaluated for metabolic syndrome irrespective of the mFG score.
Keywords: Hirsutism; Modified Ferriman–Gallwey score; metabolic syndrome; polycystic ovarian syndrome.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
The Modified Ferriman-Gallwey Score and Hirsutism among Filipino Women.Endocrinol Metab (Seoul). 2019 Dec;34(4):374-381. doi: 10.3803/EnM.2019.34.4.374. Endocrinol Metab (Seoul). 2019. PMID: 31884737 Free PMC article.
-
[Study on the facial and body terminal hair growth in women in Guangdong by using modified Ferriman-Gallwey scoring system].Zhonghua Fu Chan Ke Za Zhi. 2013 Jun;48(6):427-31. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24103121 Chinese.
-
Assessing new terminal body and facial hair growth during pregnancy: toward developing a simplified visual scoring system for hirsutism.Fertil Steril. 2016 Feb;105(2):494-500. doi: 10.1016/j.fertnstert.2015.10.036. Epub 2015 Nov 23. Fertil Steril. 2016. PMID: 26616440
-
Hirsutism, Normal Androgens and Diagnosis of PCOS.Diagnostics (Basel). 2022 Aug 9;12(8):1922. doi: 10.3390/diagnostics12081922. Diagnostics (Basel). 2022. PMID: 36010272 Free PMC article. Review.
-
[Hirsutism].Ned Tijdschr Geneeskd. 2007 Oct 20;151(42):2313-8. Ned Tijdschr Geneeskd. 2007. PMID: 18064932 Review. Dutch.
Cited by
-
Polycystic Ovarian Syndrome: Correlation between clinical hyperandrogenism, anthropometric, metabolic and endocrine parameters.Pak J Med Sci. 2019 Sep-Oct;35(5):1227-1232. doi: 10.12669/pjms.35.5.742. Pak J Med Sci. 2019. PMID: 31488983 Free PMC article.
-
Efficacy and Safety of Tracnil™ Administration in Patients with Dermatological Manifestations of PCOS: An Open-Label Single-Arm Study.Dermatol Res Pract. 2020 Mar 24;2020:7019126. doi: 10.1155/2020/7019126. eCollection 2020. Dermatol Res Pract. 2020. PMID: 32256563 Free PMC article.
-
Diagnostic value of shear wave velocity in polycystic ovarian syndrome.J Ultrason. 2021 Nov 29;21(87):e277-e281. doi: 10.15557/JoU.2021.0047. Epub 2021 Dec 15. J Ultrason. 2021. PMID: 34970437 Free PMC article.
-
The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial.Nutr J. 2020 Jan 24;19(1):8. doi: 10.1186/s12937-020-0524-5. Nutr J. 2020. PMID: 31980022 Free PMC article. Clinical Trial.
-
Comparison of the Effect of Fenugreek and Metformin on Clinical and Metabolic Status of Cases with Polycystic Ovary Syndrome: A Randomized Trial.J Reprod Infertil. 2024 Apr-Jun;25(2):120-132. doi: 10.18502/jri.v25i2.16040. J Reprod Infertil. 2024. PMID: 39157801 Free PMC article.
References
-
- Messenger AG, de Berker DA, Sinclair RD. Disorders of hair. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 8th ed. Vol. 4. West Sussex: Wiley-Blackwell; 2010. pp. 66.80–9.
-
- Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1961;21:1440–7. - PubMed
-
- Hatch R, Rosenfield RL, Kim MH, Tredway D. Hirsutism: Implications, etiology, and management. Am J Obstet Gynecol. 1981;140:815–30. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials